Literature DB >> 12011084

Crystal structures of inhibitor complexes reveal an alternate binding mode in orotidine-5'-monophosphate decarboxylase.

Ning Wu1, Emil F Pai.   

Abstract

The crystal structures of the enzyme orotidine-5'-monophosphate decarboxylase from Methanobacterium thermoautotrophicum complexed with its product UMP and the inhibitors 6-hydroxyuridine 5'-phosphate (BMP), XMP, and CMP are reported. A mutant version of the protein, in which four residues of the flexible phosphate-binding loop (180)Gly-Gly(190) were removed and Arg(203) was replaced by alanine, was also analyzed. The XMP and CMP complexes reveal a ligand-binding mode that is distinct from the one identified previously with the aromatic rings located outside the binding pocket. A potential pathway for ligand binding is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011084     DOI: 10.1074/jbc.M202362200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Polarization in the structures of uracil and thiouracils: Implication for binding with orotidine 5'-monophosphate decarboxylase.

Authors:  Sha Huang; Scott Gronert; Weiming Wu
Journal:  Bioorg Med Chem Lett       Date:  2011-09-01       Impact factor: 2.823

Review 2.  Mechanisms and free energies of enzymatic reactions.

Authors:  Jiali Gao; Shuhua Ma; Dan T Major; Kwangho Nam; Jingzhi Pu; Donald G Truhlar
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

3.  Indiscriminate binding by orotidine 5'-phosphate decarboxylase of uridine 5'-phosphate derivatives with bulky anionic c6 substituents.

Authors:  Charles A Lewis; Richard Wolfenden
Journal:  Biochemistry       Date:  2007-10-30       Impact factor: 3.162

4.  3-D clustering: a tool for high throughput docking.

Authors:  John P Priestle
Journal:  J Mol Model       Date:  2008-12-16       Impact factor: 1.810

5.  Atomic resolution structure of the orotidine 5'-monophosphate decarboxylase product complex combined with surface plasmon resonance analysis: implications for the catalytic mechanism.

Authors:  Masahiro Fujihashi; Kazuya Mito; Emil F Pai; Kunio Miki
Journal:  J Biol Chem       Date:  2013-02-10       Impact factor: 5.157

6.  Bayesian reconstruction of P(r) directly from two-dimensional detector images via a Markov chain Monte Carlo method.

Authors:  Sudeshna Paul; Alan M Friedman; Chris Bailey-Kellogg; Bruce A Craig
Journal:  J Appl Crystallogr       Date:  2013-03-05       Impact factor: 3.304

7.  Introduction of a fluorine atom at C3 of 3-deazauridine shifts its antimetabolic activity from inhibition of CTP synthetase to inhibition of orotidylate decarboxylase, an early event in the de novo pyrimidine nucleotide biosynthesis pathway.

Authors:  Jan Balzarini; Federico Gago; Wim Kulik; André B P van Kuilenburg; Anna Karlsson; Matt A Peterson; Morris J Robins
Journal:  J Biol Chem       Date:  2012-06-24       Impact factor: 5.157

8.  Substrate distortion contributes to the catalysis of orotidine 5'-monophosphate decarboxylase.

Authors:  Masahiro Fujihashi; Toyokazu Ishida; Shingo Kuroda; Lakshmi P Kotra; Emil F Pai; Kunio Miki
Journal:  J Am Chem Soc       Date:  2013-11-11       Impact factor: 15.419

9.  Structural characterization of the molecular events during a slow substrate-product transition in orotidine 5'-monophosphate decarboxylase.

Authors:  Masahiro Fujihashi; Lianhu Wei; Lakshmi P Kotra; Emil F Pai
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

Review 10.  Specificity in transition state binding: the Pauling model revisited.

Authors:  Tina L Amyes; John P Richard
Journal:  Biochemistry       Date:  2013-02-04       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.